Search research articles
Contact Us
Filters
Showing results (71-80 of 78) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 78 results.
Lancet (London, England)
|
November 9, 1985
Brain water measured in volunteers after alcohol and vasopressin
A J Mander, M A Smith, D M Kean, et al.
British Journal of Cancer
|
August 2, 2006
Multicentre phase II pharmacokinetic and pharmacodynamic study of OSI-7904L in previously untreated patients with advanced gastric or gastroesophageal junction adenocarcinoma
S Falk, A Anthoney, M Eatock, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)
|
November 30, 2000
A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse
J Chick, R Anton, K Checinski, et al.
Clinical and Translational Radiation Oncology
|
May 16, 2022
Feasibility of tumour-focused adaptive radiotherapy for bladder cancer on the MR-linac
A Mitchell, M Ingle, G Smith, et al.
Investigational New Drugs
|
March 17, 2007
A randomised phase II study of OSI-7904L versus 5-fluorouracil (FU)/leucovorin (LV) as first-line treatment in patients with advanced biliary cancers
T Ciuleanu, M Diculescu, N M Hoepffner, et al.
Cancer Chemotherapy and Pharmacology
|
May 24, 2007
A phase I and pharmacokinetic study of OSI-7904L, a liposomal thymidylate synthase inhibitor in combination with oxaliplatin in patients with advanced colorectal cancer
A R Clamp, P Schöffski, J W Valle, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
November 6, 2022
Understanding the Benefit of Magnetic Resonance-guided Adaptive Radiotherapy in Rectal Cancer Patients: a Single-centre Study
M Ingle, I White, J Chick, et al.
Clinical and Translational Radiation Oncology
|
October 5, 2020
Feasibility of magnetic resonance guided radiotherapy for the treatment of bladder cancer
A Hunt, I Hanson, A Dunlop, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 78) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 78 results.
Lancet (London, England)
|
November 9, 1985
Brain water measured in volunteers after alcohol and vasopressin
A J Mander, M A Smith, D M Kean, et al.
British Journal of Cancer
|
August 2, 2006
Multicentre phase II pharmacokinetic and pharmacodynamic study of OSI-7904L in previously untreated patients with advanced gastric or gastroesophageal junction adenocarcinoma
S Falk, A Anthoney, M Eatock, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)
|
November 30, 2000
A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse
J Chick, R Anton, K Checinski, et al.
Clinical and Translational Radiation Oncology
|
May 16, 2022
Feasibility of tumour-focused adaptive radiotherapy for bladder cancer on the MR-linac
A Mitchell, M Ingle, G Smith, et al.
Investigational New Drugs
|
March 17, 2007
A randomised phase II study of OSI-7904L versus 5-fluorouracil (FU)/leucovorin (LV) as first-line treatment in patients with advanced biliary cancers
T Ciuleanu, M Diculescu, N M Hoepffner, et al.
Cancer Chemotherapy and Pharmacology
|
May 24, 2007
A phase I and pharmacokinetic study of OSI-7904L, a liposomal thymidylate synthase inhibitor in combination with oxaliplatin in patients with advanced colorectal cancer
A R Clamp, P Schöffski, J W Valle, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
November 6, 2022
Understanding the Benefit of Magnetic Resonance-guided Adaptive Radiotherapy in Rectal Cancer Patients: a Single-centre Study
M Ingle, I White, J Chick, et al.
Clinical and Translational Radiation Oncology
|
October 5, 2020
Feasibility of magnetic resonance guided radiotherapy for the treatment of bladder cancer
A Hunt, I Hanson, A Dunlop, et al.
Page
of 8